Concepts (175)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Vaccination | 23 | 2024 | 167 | 3.350 |
Why?
|
| Colorado | 21 | 2024 | 47 | 2.320 |
Why?
|
| Asthma | 4 | 2024 | 57 | 2.150 |
Why?
|
| School Health Services | 3 | 2024 | 34 | 2.030 |
Why?
|
| Papillomavirus Vaccines | 7 | 2021 | 53 | 1.750 |
Why?
|
| Refugees | 2 | 2022 | 10 | 1.510 |
Why?
|
| Obstetrics | 8 | 2022 | 46 | 1.380 |
Why?
|
| Papillomavirus Infections | 4 | 2020 | 137 | 1.320 |
Why?
|
| Influenza Vaccines | 10 | 2022 | 48 | 1.300 |
Why?
|
| Qualitative Research | 5 | 2024 | 169 | 1.250 |
Why?
|
| Gynecology | 6 | 2022 | 55 | 1.170 |
Why?
|
| Needs Assessment | 2 | 2024 | 53 | 1.130 |
Why?
|
| Diphtheria-Tetanus-acellular Pertussis Vaccines | 7 | 2022 | 16 | 1.010 |
Why?
|
| Motivational Interviewing | 2 | 2022 | 4 | 0.950 |
Why?
|
| Immunization Programs | 2 | 2024 | 12 | 0.920 |
Why?
|
| Patient Acceptance of Health Care | 3 | 2020 | 84 | 0.910 |
Why?
|
| Parents | 6 | 2024 | 121 | 0.890 |
Why?
|
| Social Determinants of Health | 1 | 2024 | 30 | 0.890 |
Why?
|
| Prenatal Care | 2 | 2020 | 40 | 0.850 |
Why?
|
| Practice Patterns, Physicians' | 4 | 2019 | 160 | 0.850 |
Why?
|
| Health Services Research | 2 | 2019 | 40 | 0.830 |
Why?
|
| Community Participation | 2 | 2021 | 25 | 0.780 |
Why?
|
| Health Knowledge, Attitudes, Practice | 8 | 2021 | 279 | 0.740 |
Why?
|
| Stakeholder Participation | 1 | 2020 | 5 | 0.740 |
Why?
|
| Humans | 37 | 2024 | 26789 | 0.740 |
Why?
|
| Private Practice | 1 | 2020 | 8 | 0.740 |
Why?
|
| Female | 29 | 2024 | 14434 | 0.730 |
Why?
|
| Mothers | 7 | 2022 | 107 | 0.720 |
Why?
|
| Child | 10 | 2024 | 2141 | 0.710 |
Why?
|
| Pregnancy | 16 | 2022 | 1127 | 0.700 |
Why?
|
| Patient Outcome Assessment | 1 | 2019 | 13 | 0.680 |
Why?
|
| Documentation | 1 | 2019 | 24 | 0.660 |
Why?
|
| Influenza, Human | 5 | 2022 | 84 | 0.640 |
Why?
|
| Electronic Health Records | 1 | 2019 | 59 | 0.630 |
Why?
|
| Pediatrics | 1 | 2019 | 87 | 0.620 |
Why?
|
| Human Development | 1 | 2018 | 4 | 0.620 |
Why?
|
| Whooping Cough | 5 | 2022 | 15 | 0.590 |
Why?
|
| Learning | 1 | 2018 | 92 | 0.570 |
Why?
|
| Young Adult | 8 | 2024 | 2576 | 0.530 |
Why?
|
| Students | 1 | 2018 | 188 | 0.520 |
Why?
|
| Pregnant Women | 7 | 2022 | 23 | 0.510 |
Why?
|
| Adolescent | 9 | 2024 | 2951 | 0.510 |
Why?
|
| Patient Education as Topic | 3 | 2020 | 87 | 0.480 |
Why?
|
| Adult | 15 | 2024 | 7365 | 0.440 |
Why?
|
| Infant | 10 | 2022 | 954 | 0.440 |
Why?
|
| Male | 10 | 2024 | 12854 | 0.410 |
Why?
|
| Interviews as Topic | 2 | 2024 | 150 | 0.380 |
Why?
|
| Vaccines | 2 | 2022 | 30 | 0.380 |
Why?
|
| Diphtheria | 3 | 2022 | 4 | 0.370 |
Why?
|
| Tetanus | 3 | 2022 | 5 | 0.370 |
Why?
|
| Mass Screening | 2 | 2024 | 141 | 0.340 |
Why?
|
| Ambulatory Care | 2 | 2019 | 58 | 0.330 |
Why?
|
| Attitude to Health | 3 | 2020 | 86 | 0.330 |
Why?
|
| Mobile Applications | 2 | 2020 | 55 | 0.320 |
Why?
|
| Immunization | 4 | 2022 | 117 | 0.310 |
Why?
|
| Surveys and Questionnaires | 7 | 2021 | 916 | 0.300 |
Why?
|
| Primary Health Care | 2 | 2020 | 145 | 0.280 |
Why?
|
| Antipsychotic Agents | 2 | 2016 | 24 | 0.260 |
Why?
|
| Medicaid | 2 | 2016 | 52 | 0.260 |
Why?
|
| Blood Glucose | 2 | 2016 | 300 | 0.240 |
Why?
|
| Delphi Technique | 1 | 2024 | 17 | 0.230 |
Why?
|
| Research Design | 2 | 2022 | 174 | 0.230 |
Why?
|
| Delivery of Health Care | 2 | 2022 | 111 | 0.220 |
Why?
|
| Georgia | 5 | 2021 | 21 | 0.220 |
Why?
|
| Health Services Accessibility | 1 | 2024 | 89 | 0.220 |
Why?
|
| Immunization Schedule | 2 | 2019 | 9 | 0.210 |
Why?
|
| Pilot Projects | 1 | 2024 | 387 | 0.210 |
Why?
|
| Intention | 2 | 2020 | 75 | 0.210 |
Why?
|
| Infant, Newborn | 3 | 2020 | 841 | 0.200 |
Why?
|
| Research Personnel | 1 | 2022 | 34 | 0.200 |
Why?
|
| Quality Improvement | 2 | 2020 | 112 | 0.200 |
Why?
|
| Language | 1 | 2022 | 62 | 0.190 |
Why?
|
| Ambulatory Care Facilities | 2 | 2019 | 51 | 0.190 |
Why?
|
| Policy Making | 1 | 2021 | 12 | 0.190 |
Why?
|
| Bhutan | 1 | 2020 | 2 | 0.180 |
Why?
|
| Alphapapillomavirus | 1 | 2020 | 8 | 0.170 |
Why?
|
| Child Health | 1 | 2019 | 15 | 0.170 |
Why?
|
| Community-Based Participatory Research | 1 | 2019 | 32 | 0.170 |
Why?
|
| Health Care Surveys | 1 | 2019 | 67 | 0.160 |
Why?
|
| Carbon | 2 | 2012 | 93 | 0.160 |
Why?
|
| Patient Participation | 1 | 2019 | 52 | 0.160 |
Why?
|
| Patient Compliance | 1 | 2019 | 75 | 0.160 |
Why?
|
| Communication | 1 | 2020 | 166 | 0.160 |
Why?
|
| Parenting | 1 | 2019 | 56 | 0.160 |
Why?
|
| Information Seeking Behavior | 1 | 2018 | 13 | 0.160 |
Why?
|
| Family Relations | 1 | 2018 | 11 | 0.150 |
Why?
|
| Decision Making | 1 | 2019 | 169 | 0.150 |
Why?
|
| Universities | 1 | 2018 | 115 | 0.150 |
Why?
|
| Standing Orders | 1 | 2016 | 1 | 0.140 |
Why?
|
| Amyloid Precursor Protein Secretases | 2 | 2007 | 23 | 0.140 |
Why?
|
| State Health Plans | 1 | 2016 | 3 | 0.140 |
Why?
|
| Middle Aged | 3 | 2024 | 6803 | 0.140 |
Why?
|
| Bipolar Disorder | 1 | 2016 | 39 | 0.130 |
Why?
|
| Community Mental Health Services | 1 | 2016 | 15 | 0.130 |
Why?
|
| Aged | 2 | 2024 | 5155 | 0.130 |
Why?
|
| Drug Prescriptions | 1 | 2016 | 43 | 0.130 |
Why?
|
| Schizophrenia | 1 | 2016 | 45 | 0.130 |
Why?
|
| Infectious Disease Transmission, Vertical | 1 | 2015 | 13 | 0.130 |
Why?
|
| Attitude of Health Personnel | 1 | 2016 | 139 | 0.130 |
Why?
|
| Lipids | 1 | 2016 | 195 | 0.120 |
Why?
|
| Health Promotion | 1 | 2015 | 169 | 0.110 |
Why?
|
| Diabetes Mellitus | 1 | 2016 | 207 | 0.110 |
Why?
|
| United States | 4 | 2021 | 2029 | 0.110 |
Why?
|
| Age Factors | 1 | 2015 | 714 | 0.100 |
Why?
|
| Hydro-Lyases | 1 | 2012 | 8 | 0.100 |
Why?
|
| Lignin | 1 | 2012 | 15 | 0.100 |
Why?
|
| Neoplasms | 1 | 2020 | 748 | 0.090 |
Why?
|
| Pertussis Vaccine | 2 | 2022 | 6 | 0.080 |
Why?
|
| Alkenes | 2 | 2006 | 15 | 0.080 |
Why?
|
| Sulfur | 1 | 2007 | 33 | 0.070 |
Why?
|
| Protease Inhibitors | 1 | 2007 | 40 | 0.070 |
Why?
|
| Missouri | 2 | 2016 | 9 | 0.070 |
Why?
|
| Hydrocarbons, Aromatic | 1 | 2006 | 9 | 0.070 |
Why?
|
| Nitriles | 1 | 2006 | 32 | 0.070 |
Why?
|
| Oxides | 1 | 2006 | 14 | 0.070 |
Why?
|
| Enzyme Inhibitors | 1 | 2006 | 247 | 0.060 |
Why?
|
| Vulnerable Populations | 1 | 2024 | 46 | 0.060 |
Why?
|
| Vaccination Coverage | 1 | 2022 | 11 | 0.050 |
Why?
|
| Schools | 1 | 2022 | 69 | 0.050 |
Why?
|
| Rural Population | 1 | 2021 | 89 | 0.050 |
Why?
|
| Social Networking | 1 | 2020 | 5 | 0.040 |
Why?
|
| Vaccination Refusal | 1 | 2019 | 2 | 0.040 |
Why?
|
| Patient Satisfaction | 1 | 2019 | 89 | 0.040 |
Why?
|
| Psychometrics | 1 | 2019 | 117 | 0.040 |
Why?
|
| Pediatricians | 1 | 2018 | 4 | 0.040 |
Why?
|
| Urban Health Services | 1 | 2018 | 8 | 0.040 |
Why?
|
| Rural Health Services | 1 | 2018 | 22 | 0.040 |
Why?
|
| Models, Theoretical | 1 | 2019 | 129 | 0.040 |
Why?
|
| Internet | 1 | 2019 | 121 | 0.040 |
Why?
|
| Socioeconomic Factors | 1 | 2019 | 241 | 0.040 |
Why?
|
| Postpartum Period | 1 | 2018 | 63 | 0.040 |
Why?
|
| Health Behavior | 1 | 2019 | 153 | 0.040 |
Why?
|
| Physician Executives | 1 | 2016 | 5 | 0.030 |
Why?
|
| Administrative Personnel | 1 | 2016 | 6 | 0.030 |
Why?
|
| Stereoisomerism | 2 | 2007 | 45 | 0.030 |
Why?
|
| Allied Health Personnel | 1 | 2016 | 14 | 0.030 |
Why?
|
| Nurses | 1 | 2016 | 13 | 0.030 |
Why?
|
| Patient Preference | 1 | 2016 | 28 | 0.030 |
Why?
|
| Diphtheria Toxoid | 1 | 2015 | 1 | 0.030 |
Why?
|
| Tetanus Toxoid | 1 | 2015 | 4 | 0.030 |
Why?
|
| Administration, Oral | 1 | 2016 | 166 | 0.030 |
Why?
|
| Molecular Structure | 2 | 2007 | 239 | 0.030 |
Why?
|
| Child, Preschool | 1 | 2019 | 1087 | 0.030 |
Why?
|
| Evidence-Based Practice | 1 | 2015 | 30 | 0.030 |
Why?
|
| Social Behavior | 1 | 2015 | 52 | 0.030 |
Why?
|
| Risk | 1 | 2015 | 133 | 0.030 |
Why?
|
| Evidence-Based Medicine | 1 | 2016 | 140 | 0.030 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2016 | 356 | 0.030 |
Why?
|
| Time Factors | 1 | 2018 | 1563 | 0.030 |
Why?
|
| Risk Assessment | 1 | 2016 | 586 | 0.030 |
Why?
|
| Cohort Studies | 1 | 2016 | 857 | 0.030 |
Why?
|
| Chloroplasts | 1 | 2012 | 4 | 0.030 |
Why?
|
| Cross-Sectional Studies | 1 | 2015 | 908 | 0.030 |
Why?
|
| Glucuronidase | 1 | 2012 | 9 | 0.030 |
Why?
|
| Gene Knockout Techniques | 1 | 2012 | 35 | 0.020 |
Why?
|
| Acetates | 1 | 2012 | 44 | 0.020 |
Why?
|
| Isoenzymes | 1 | 2012 | 86 | 0.020 |
Why?
|
| Gene Expression Regulation, Plant | 1 | 2012 | 69 | 0.020 |
Why?
|
| Protein Transport | 1 | 2012 | 152 | 0.020 |
Why?
|
| Arabidopsis | 1 | 2012 | 65 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2016 | 2425 | 0.020 |
Why?
|
| Phenotype | 1 | 2012 | 664 | 0.020 |
Why?
|
| Keto Acids | 1 | 2007 | 3 | 0.020 |
Why?
|
| Fluorine | 1 | 2007 | 5 | 0.020 |
Why?
|
| Crystallization | 1 | 2007 | 47 | 0.020 |
Why?
|
| Magnesium | 1 | 2007 | 40 | 0.020 |
Why?
|
| Solubility | 1 | 2007 | 73 | 0.020 |
Why?
|
| Sulfides | 1 | 2007 | 38 | 0.020 |
Why?
|
| Amino Alcohols | 1 | 2006 | 3 | 0.020 |
Why?
|
| Tartrates | 1 | 2006 | 2 | 0.020 |
Why?
|
| Sulfones | 1 | 2006 | 7 | 0.020 |
Why?
|
| Temperature | 1 | 2007 | 207 | 0.020 |
Why?
|
| Molecular Conformation | 1 | 2006 | 66 | 0.020 |
Why?
|
| Oxidation-Reduction | 1 | 2007 | 354 | 0.020 |
Why?
|
| Crystallography, X-Ray | 1 | 2006 | 214 | 0.020 |
Why?
|